Intec Pharma Ltd
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Intec Pharma Ltd generated cash of -$11,511,000, which is more than the previous year. Cash used in financing activities reached the amount of $15,978,000 last year. Net change in cash is therefore $5,379,000.
Cash Flow
| 2013 | -3.50M | -3.23M | 9.62M |
|---|---|---|---|
| 2014 | -4.75M | 2.78M | 4.68M |
| 2015 | -7.88M | -6.34M | 31.78M |
| 2016 | -12.00M | 4.72M | 0 |
| 2017 | -22.13M | -4.74M | 63.70M |
| 2018 | -39.07M | -9.30M | 35.05M |
| 2019 | -29.04M | -3.21M | 2.36M |
| 2020 | -11.51M | 750K | 15.97M |
NTEC Cash Flow Statement (2013 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 9.29M | 39.24M | 53.39M | 16.37M | 23.64M | 5.70M | 3.38M | 560.80K |
Operating activities | ||||||||
Net income | -14.12M | -47.59M | -43.54M | -29.09M | -13.36M | -7.14M | -5.69M | -5.28M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 1.20M | 854K | 859K | 829K | 701K | 742.38K | 585K | 624.83K |
Stock-based compensation expense | 1.14M | 3.22M | 3.22M | 1.20M | 536K | 379.13K | 337K | 525.19K |
| Deferred income tax benefit | 1.14M | 3.22M | 3.22M | 1.20M | 536K | 379.13K | 337K | 525.19K |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 3.38M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | -5.72M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -3.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -11.51M | -29.04M | -39.07M | -22.13M | -12.00M | -7.88M | -4.75M | -3.50M |
Investing activities | ||||||||
Purchases Of Investments | 0 | -2.86M | -4.93M | 0 | 0 | -4.97M | 0 | -1.70M |
Investments In Property Plant And Equipment | -22K | -3.78M | -9.59M | -5.00M | -482K | -1.38M | -76K | -1.54M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 750K | -3.21M | -9.30M | -4.74M | 4.72M | -6.34M | 2.78M | -3.23M |
Financing activities | ||||||||
Common Stock Issued | 15.13M | 2.08M | 35.02M | 63.13M | 0 | 29.91M | 4.51M | 9.39M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 15.97M | 2.36M | 35.05M | 63.70M | 0 | 31.78M | 4.68M | 9.62M |
Net Change In Cash | 5.37M | -29.95M | -14.14M | 36.94M | -7.27M | 17.92M | 2.34M | 2.81M |
Cash at end of period | 14.67M | 9.29M | 39.24M | 53.32M | 16.37M | 23.63M | 5.73M | 3.37M |
| Data source | Data source |